Thus, the aim of our study was to assess the outcome potential of classical and novel imaging variables (radiomics) obtained from 18F-fluorocholine PET/CT and compare their performance with the standard of imaging care CE-MRI together with other clinical factors related to prognosis in patients with IDH-wt high-grade gliomas. The gene discussed is IDH1; the disease is glioma.